Nandan Kulkarni

Stock Analyst at Bernstein

(1.27)
# 3,779
Out of 5,126 analysts
4
Total ratings
n/a
Success rate
-6.1%
Average return

Stocks Rated by Nandan Kulkarni

Mankind Pharma Limited
Oct 26, 2026
Reiterated: Sell
Price Target: ₹2,057
Current: ₹2,641
Upside: -22.12%